Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sen. Baucus, Key Architect Of Device Tax, Health Reform, To Retire In 2014

This article was originally published in The Gray Sheet

Executive Summary

Sen. Max Baucus, D-Mont., chairman of the powerful Senate Finance Committee, and one of the key architects of the Affordable Care Act and device tax, says he will serve out his term, but not seek re-election in November 2014.

You may also be interested in...



People Briefs: Baucus Leaves Senate; Commerce Staffer Departure; Philips North America, NuVasive Executive Changes

Sen. Max Baucus, D-Mont., is confirmed as new ambassador to China and expected to depart the Senate soon. Commerce Department Director of Office of Health and IT departs. More people briefs.

PCORI In Brief: New Board Member, Funding Opportunities

The Patient-Centered Outcomes Research Institute welcomes UCSF professor Alicia Fernandez to the board, announces pragmatic trials funding opportunity; Senate bids farewell to PCORI champion Max Baucus.

FDA Budget, Physician Payments On Tap For Congress In The New Year

Congress is on a tight schedule to approve federal appropriations bills for FDA and other agencies. It may also take up comprehensive physician payment reform bills that passed out of committees late in 2013, legislation that could have important implications for the device space. Also to look out for: a changing of the guard in the powerful Senate Finance Committee.

Related Content

Topics

UsernamePublicRestriction

Register

OM004559

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel